Nurse Practitioner in Avilla, IN Accepting Medicare
3 Nurse Practitioner nurses found. Showing 1 - 3
 Kourtney Marie Terry, NP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 128 Miner Rd, Avilla, IN 46710 Phone: 260-226-0388 |
Ronda L Lehn, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 104 Nicholas Place,, Box 859, Avilla, IN 46710 Phone: 260-897-3308 Fax: 260-897-3650 |
Donna Hackman, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 104 Nicholas Place, Avilla, IN 46710 Phone: 260-897-3308 Fax: 260-897-3650 |
News Archive
College freshies show weaker immune responses
Being a college freshie may have more ramifications than being lonely and missing Mum's cooking, according to a new study at Carnegie Mellon University in Pittsburgh which shows that first-year students had a weaker immune response to the flu shot than did other students, and confirms suspicions that going to college challenges both mind and body.
World Health Assembly underscores need for multisectoral action to achieve health-related SDGs
Christiana Figueres, Executive Secretary of the United Nations Framework Convention on Climate Change, addressed the World Health Assembly today.
Major study to assess effectiveness of mindfulness training in UK schools
The three-part study includes the first large randomised control trial of mindfulness training compared with 'teaching as usual' in 76 schools, which will involve nearly six thousand students aged 11 to 14. Other parts of the study are a programme of experimental research to establish whether and how mindfulness improves the mental resilience of teenagers, and an evaluation of the most effective way to train teachers to deliver mindfulness classes to students.
First comparative data of encorafenib and paradox breaker inhibitors in BRAF mutant CRC
Oncotarget Volume 11, Issue 34 features Figure 1, "BRAF inhibitor-induced changes in cell viability," by Pickles, et al which reported that the BEACON CRC trial demonstrated a survival advantage over chemotherapy for a combination of targeted agents comprising the potent BRAF inhibitor encorafenib together with cetuximab and binimetinib.
› Verified 4 days ago